msa-20230331false2023Q10000066570--12-31P3Y00000665702023-01-012023-03-3100000665702023-04-21xbrli:sharesiso4217:USD00000665702022-01-012022-03-31iso4217:USDxbrli:shares00000665702023-03-3100000665702022-12-31xbrli:pure00000665702022-01-012022-09-3000000665702021-12-3100000665702022-03-310000066570us-gaap:RetainedEarningsMember2021-12-310000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000066570us-gaap:RetainedEarningsMember2022-01-012022-03-310000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000066570us-gaap:RetainedEarningsMember2022-03-310000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000066570us-gaap:RetainedEarningsMember2022-12-310000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000066570us-gaap:RetainedEarningsMember2023-01-012023-03-310000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000066570us-gaap:RetainedEarningsMember2023-03-310000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000066570msa:AmericasSegmentMember2023-01-012023-03-310000066570us-gaap:CorporateMember2023-01-012023-03-310000066570msa:InternationalMember2022-01-012022-03-310000066570msa:AmericasSegmentMember2022-01-012022-03-310000066570msa:AmericasSegmentMember2021-12-310000066570msa:InternationalMember2021-12-310000066570us-gaap:CorporateNonSegmentMember2021-12-310000066570msa:AmericasSegmentMember2022-01-012022-06-300000066570msa:InternationalMember2022-01-012022-06-300000066570us-gaap:CorporateNonSegmentMember2022-01-012022-06-3000000665702022-01-012022-06-300000066570msa:AmericasSegmentMember2022-12-310000066570msa:InternationalMember2022-12-310000066570us-gaap:CorporateNonSegmentMember2022-12-310000066570msa:InternationalMember2023-01-012023-03-310000066570us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000066570msa:AmericasSegmentMember2023-03-310000066570msa:InternationalMember2023-03-310000066570us-gaap:CorporateNonSegmentMember2023-03-310000066570us-gaap:LandMember2023-03-310000066570us-gaap:LandMember2022-12-310000066570us-gaap:BuildingMember2023-03-310000066570us-gaap:BuildingMember2022-12-310000066570us-gaap:MachineryAndEquipmentMember2023-03-310000066570us-gaap:MachineryAndEquipmentMember2022-12-310000066570us-gaap:ConstructionInProgressMember2023-03-310000066570us-gaap:ConstructionInProgressMember2022-12-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2023-01-012023-03-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2022-01-012022-03-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-01-012023-03-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-01-012022-03-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-03-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-310000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-03-310000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-03-310000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-03-310000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-03-310000066570us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000066570us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000066570us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000066570us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310000066570us-gaap:CumulativePreferredStockMember2023-03-310000066570us-gaap:CumulativePreferredStockMember2023-01-012023-03-310000066570us-gaap:PreferredStockMember2023-03-310000066570msa:SecondCumulativePreferredVotingStockMember2023-03-310000066570us-gaap:CommonStockMember2022-12-310000066570us-gaap:CommonStockMember2023-01-012023-03-310000066570us-gaap:CommonStockMember2022-01-012022-03-310000066570us-gaap:CommonStockMember2023-03-310000066570us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000066570us-gaap:TreasuryStockCommonMember2022-01-012022-03-310000066570us-gaap:CommonStockMember2022-12-310000066570us-gaap:TreasuryStockCommonMember2022-12-310000066570us-gaap:CommonStockMember2021-12-310000066570us-gaap:TreasuryStockCommonMember2021-12-310000066570us-gaap:CommonStockMember2023-01-012023-03-310000066570us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000066570us-gaap:CommonStockMember2022-01-012022-03-310000066570us-gaap:TreasuryStockCommonMember2022-01-012022-03-310000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:CommonStockMember2023-01-012023-03-310000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:TreasuryStockCommonMember2023-01-012023-03-310000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:CommonStockMember2022-01-012022-03-310000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:TreasuryStockCommonMember2022-01-012022-03-310000066570us-gaap:CommonStockMemberus-gaap:EmployeeStockOptionMember2023-01-012023-03-310000066570us-gaap:TreasuryStockCommonMemberus-gaap:EmployeeStockOptionMember2023-01-012023-03-310000066570us-gaap:CommonStockMemberus-gaap:EmployeeStockOptionMember2022-01-012022-03-310000066570us-gaap:TreasuryStockCommonMemberus-gaap:EmployeeStockOptionMember2022-01-012022-03-310000066570us-gaap:StockCompensationPlanMemberus-gaap:CommonStockMember2023-01-012023-03-310000066570us-gaap:StockCompensationPlanMemberus-gaap:TreasuryStockCommonMember2023-01-012023-03-310000066570us-gaap:StockCompensationPlanMemberus-gaap:CommonStockMember2022-01-012022-03-310000066570us-gaap:StockCompensationPlanMemberus-gaap:TreasuryStockCommonMember2022-01-012022-03-310000066570us-gaap:CommonStockMember2023-03-310000066570us-gaap:TreasuryStockCommonMember2023-03-310000066570us-gaap:CommonStockMember2022-03-310000066570us-gaap:TreasuryStockCommonMember2022-03-31msa:Segment0000066570msa:AmericasSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000066570msa:InternationalSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000066570msa:AmericasSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000066570msa:InternationalSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000066570us-gaap:CorporateNonSegmentMember2022-01-012022-03-310000066570msa:FixGasFlameDetectionInstrumentsMember2023-01-012023-03-310000066570msa:FixGasFlameDetectionInstrumentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:FixGasFlameDetectionInstrumentsMembermsa:InternationalMember2023-01-012023-03-310000066570msa:FixGasFlameDetectionInstrumentsMemberus-gaap:ProductConcentrationRiskMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:BreathingApparatusMember2023-01-012023-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:BreathingApparatusMember2023-01-012023-03-310000066570msa:AmericasSegmentMemberus-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:BreathingApparatusMembermsa:InternationalMember2023-01-012023-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:FirefighterHelmetsandProtectiveApparelMember2023-01-012023-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-01-012023-03-310000066570msa:AmericasSegmentMemberus-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:FirefighterHelmetsandProtectiveApparelMembermsa:InternationalMember2023-01-012023-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:InternationalMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:PortableInstrumentsMember2023-01-012023-03-310000066570msa:PortableInstrumentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:PortableInstrumentsMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:PortableInstrumentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:PortableInstrumentsMembermsa:InternationalMember2023-01-012023-03-310000066570msa:PortableInstrumentsMemberus-gaap:ProductConcentrationRiskMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:HeadProtectionMember2023-01-012023-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:HeadProtectionMember2023-01-012023-03-310000066570msa:AmericasSegmentMemberus-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:HeadProtectionMembermsa:InternationalMember2023-01-012023-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:FallProtectionMember2023-01-012023-03-310000066570msa:FallProtectionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:FallProtectionMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:FallProtectionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:FallProtectionMembermsa:InternationalMember2023-01-012023-03-310000066570msa:FallProtectionMemberus-gaap:ProductConcentrationRiskMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:OtherProductsMember2023-01-012023-03-310000066570msa:OtherProductsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:OtherProductsMember2023-01-012023-03-310000066570msa:AmericasSegmentMembermsa:OtherProductsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:OtherProductsMembermsa:InternationalMember2023-01-012023-03-310000066570msa:OtherProductsMemberus-gaap:ProductConcentrationRiskMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:AmericasSegmentMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000066570msa:FixGasFlameDetectionInstrumentsMember2022-01-012022-03-310000066570msa:FixGasFlameDetectionInstrumentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:FixGasFlameDetectionInstrumentsMembermsa:InternationalMember2022-01-012022-03-310000066570msa:FixGasFlameDetectionInstrumentsMemberus-gaap:ProductConcentrationRiskMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:BreathingApparatusMember2022-01-012022-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:BreathingApparatusMember2022-01-012022-03-310000066570msa:AmericasSegmentMemberus-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:BreathingApparatusMembermsa:InternationalMember2022-01-012022-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:FirefighterHelmetsandProtectiveApparelMember2022-01-012022-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-01-012022-03-310000066570msa:AmericasSegmentMemberus-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:FirefighterHelmetsandProtectiveApparelMembermsa:InternationalMember2022-01-012022-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:InternationalMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:PortableInstrumentsMember2022-01-012022-03-310000066570msa:PortableInstrumentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:PortableInstrumentsMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:PortableInstrumentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:PortableInstrumentsMembermsa:InternationalMember2022-01-012022-03-310000066570msa:PortableInstrumentsMemberus-gaap:ProductConcentrationRiskMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:HeadProtectionMember2022-01-012022-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:HeadProtectionMember2022-01-012022-03-310000066570msa:AmericasSegmentMemberus-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:HeadProtectionMembermsa:InternationalMember2022-01-012022-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:FallProtectionMember2022-01-012022-03-310000066570msa:FallProtectionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:FallProtectionMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:FallProtectionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:FallProtectionMembermsa:InternationalMember2022-01-012022-03-310000066570msa:FallProtectionMemberus-gaap:ProductConcentrationRiskMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:OtherProductsMember2022-01-012022-03-310000066570msa:OtherProductsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:OtherProductsMember2022-01-012022-03-310000066570msa:AmericasSegmentMembermsa:OtherProductsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:OtherProductsMembermsa:InternationalMember2022-01-012022-03-310000066570msa:OtherProductsMemberus-gaap:ProductConcentrationRiskMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:AmericasSegmentMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570us-gaap:ProductConcentrationRiskMembermsa:InternationalMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000066570msa:DeferredTaxAssetMember2023-03-310000066570us-gaap:RestrictedStockMember2022-12-310000066570us-gaap:RestrictedStockMember2023-01-012023-03-310000066570us-gaap:RestrictedStockMember2023-03-310000066570srt:MinimumMember2023-01-012023-03-310000066570srt:MaximumMember2023-01-012023-03-310000066570msa:MonteCarloApproachMemberus-gaap:PerformanceSharesMember2023-01-012023-03-310000066570us-gaap:PerformanceSharesMember2023-01-012023-03-310000066570us-gaap:PerformanceSharesMember2022-12-310000066570us-gaap:PerformanceSharesMember2023-03-310000066570msa:SeniorNotesPayableThroughTwoThousandThirtyOneThreePointFourPercentageMemberMember2023-03-310000066570msa:SeniorNotesPayableThroughTwoThousandThirtyOneThreePointFourPercentageMemberMember2022-12-310000066570msa:MultiCurrencyNoteSeriesCSeniorNotesMember2023-03-310000066570msa:MultiCurrencyNoteSeriesCSeniorNotesMember2022-12-310000066570msa:NYLNoteFacilitySeriesASeniorNotesMember2023-03-310000066570msa:NYLNoteFacilitySeriesASeniorNotesMember2022-12-310000066570us-gaap:SecuredDebtMemberus-gaap:LineOfCreditMembermsa:TermLoanFacility2023Member2023-03-310000066570us-gaap:SecuredDebtMemberus-gaap:LineOfCreditMembermsa:TermLoanFacility2023Member2022-12-3100000665702021-05-240000066570us-gaap:BaseRateMembermsa:SeniorRevolvingCreditFacilityMaturingIn2026Member2021-05-242021-05-240000066570msa:FederalFundsOpenRateMembermsa:SeniorRevolvingCreditFacilityMaturingIn2026Member2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Membermsa:OvernightBankFundingRateMember2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Memberus-gaap:LondonInterbankOfferedRateLIBORMember2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Membersrt:MinimumMember2021-05-242021-05-240000066570srt:MaximumMembermsa:SeniorRevolvingCreditFacilityMaturingIn2026Member2021-05-242021-05-240000066570us-gaap:SeniorNotesMembermsa:MultiCurrencyNoteSeriesCSeniorNotesMember2021-07-010000066570us-gaap:UnsecuredDebtMembermsa:MultiCurrencyNoteSeriesCSeniorNotesMember2021-07-010000066570us-gaap:NotesPayableOtherPayablesMembermsa:MulticurrencyNotesDuein2031Member2023-03-31iso4217:GBP0000066570us-gaap:NotesPayableOtherPayablesMembermsa:MulticurrencyNotesDuein2031Member2023-01-012023-03-310000066570msa:NYLNoteFacilitySeriesASeniorNotesMemberus-gaap:SeniorNotesMember2021-07-010000066570msa:NYLNoteFacilitySeniorUnsecuredNotesMemberus-gaap:SeniorNotesMember2021-07-0100000665702019-01-042019-01-040000066570us-gaap:SecuredDebtMemberus-gaap:LineOfCreditMembermsa:TermLoanFacility2023Member2023-01-050000066570us-gaap:SecuredDebtMemberus-gaap:LineOfCreditMembermsa:TermLoanFacility2023Membersrt:MinimumMember2023-01-052023-01-050000066570us-gaap:SecuredDebtMembersrt:MaximumMemberus-gaap:LineOfCreditMembermsa:TermLoanFacility2023Member2023-01-052023-01-050000066570us-gaap:StandbyLettersOfCreditMember2023-03-310000066570us-gaap:StandbyLettersOfCreditMembermsa:SeniorRevolvingCreditFacilityMaturingIn2026Member2023-03-310000066570msa:InternationalSegmentMember2023-03-310000066570msa:GlobeHoldingCompanyLLCMemberus-gaap:TradeNamesMember2023-03-310000066570us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000066570us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-03-310000066570us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-03-310000066570us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-03-310000066570us-gaap:ForeignExchangeForwardMember2023-03-310000066570us-gaap:ForeignExchangeForwardMember2022-12-310000066570us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-03-310000066570us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-12-310000066570us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2023-03-310000066570us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2022-12-310000066570us-gaap:NondesignatedMember2023-01-012023-03-310000066570us-gaap:NondesignatedMember2022-01-012022-03-310000066570us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000066570us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000066570us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000066570us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000066570msa:SingleIncidentMember2023-03-310000066570msa:SingleIncidentMember2022-12-310000066570msa:SingleIncidentMember2022-01-012022-03-310000066570msa:SingleIncidentMember2023-01-012023-03-310000066570msa:CumulativeTraumaMember2022-12-310000066570msa:ClaimsSettledButNotYetPaidMember2022-12-310000066570msa:CumulativeTraumaMemberus-gaap:OtherCurrentLiabilitiesMember2022-12-310000066570msa:CumulativeTraumaMemberus-gaap:OtherNoncurrentLiabilitiesMember2022-12-310000066570msa:MSALLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-052023-01-050000066570msa:MSALLCMembermsa:JointVentureByRQInsuranceHoldingsLtdAndObraCapitalIncMember2023-01-052023-01-050000066570msa:MSALLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-012023-03-3100000665702022-01-012022-12-310000066570msa:DamagesFromProductSubstancesMemberus-gaap:SubsequentEventMember2023-05-02msa:lawsuitmsa:claimmsa:class_action
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended March 31, 2023
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File No. 1-15579
MSA SAFETY INCORPORATED
(Exact name of registrant as specified in its charter)
| | | | | | | | | | | |
Pennsylvania | | 46-4914539 |
(State or other jurisdiction of incorporation or organization) | | (IRS Employer Identification No.) |
| | |
1000 Cranberry Woods Drive | | |
Cranberry Township, | Pennsylvania | | 16066-5207 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (724) 776-8600
Former name or former address, if changed since last report: N/A
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | | | | | | | | | | | | | |
Large Accelerated Filer | x | Accelerated filer | ¨ | Non-accelerated filer | ¨ | Smaller reporting company | ☐ |
| | | | | | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
Title of each class | Trading Symbol(s) | Name of each exchange on which is registered |
Common Stock, no par value | MSA | New York Stock Exchange |
As of April 21, 2023, 39,267,074 shares of common stock, of the registrant were outstanding.
| | | | | | | | |
Item No. | | Page |
Part I | | |
1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
2. | | |
3. | | |
4. | | |
Part II | | |
2. | | |
6. | | |
| | |
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Unaudited
| | | | | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, | |
(In thousands, except per share values) | | | | | 2023 | | 2022 | |
Net sales | | | | | $ | 398,262 | | | $ | 330,692 | | |
Cost of products sold | | | | | 216,864 | | | 187,908 | | |
Gross profit | | | | | 181,398 | | | 142,784 | | |
| | | | | | | | |
Selling, general and administrative | | | | | 91,091 | | | 78,551 | | |
Research and development | | | | | 15,232 | | | 13,333 | | |
Restructuring charges (Note 3) | | | | | 1,747 | | | 2,189 | | |
Currency exchange losses, net | | | | | 4,175 | | | 3,271 | | |
Loss on divestiture of MSA LLC (Note 17) | | | | | 129,211 | | | — | | |
Product liability expense (Note 17) | | | | | 3 | | | 2,772 | | |
Operating (loss) income | | | | | (60,061) | | | 42,668 | | |
| | | | | | | | |
Interest expense | | | | | 11,476 | | | 3,618 | | |
| | | | | | | | |
Other income, net | | | | | (3,800) | | | (6,344) | | |
Total other expense (income), net | | | | | 7,676 | | | (2,726) | | |
| | | | | | | | |
(Loss) income before income taxes | | | | | (67,737) | | | 45,394 | | |
Provision for income taxes (Note 10) | | | | | 82,436 | | | 9,852 | | |
Net (loss) income | | | | | $ | (150,173) | | | $ | 35,542 | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
(Loss) earnings per share attributable to common shareholders (Note 9): | | | | | | | | |
Basic | | | | | $ | (3.83) | | | $ | 0.90 | | |
Diluted | | | | | $ | (3.83) | | | $ | 0.90 | | |
Dividends per common share | | | | | $ | 0.46 | | | $ | 0.44 | | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
Unaudited
| | | | | | | | | | | | | | | | | |
| | | Three Months Ended March 31, |
(In thousands) | | | | | 2023 | | 2022 |
Net (loss) income | | | | | $ | (150,173) | | | $ | 35,542 | |
Other comprehensive gains, net of tax: | | | | | | | |
Foreign currency translation adjustments (Note 6) | | | | | 11,194 | | | 5,892 | |
Pension and post-retirement plan actuarial gains, net of tax (Note 6) | | | | | 439 | | | 2,264 | |
Unrealized gains (losses) on available-for-sale securities (Note 6) | | | | | 2 | | | (9) | |
| | | | | | | |
Total other comprehensive gains, net of tax | | | | | 11,635 | | | 8,147 | |
Comprehensive (loss) income | | | | | $ | (138,538) | | | $ | 43,689 | |
| | | | | | | |
| | | | | | | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS
Unaudited
| | | | | | | | | | | | | | |
(In thousands) | | March 31, 2023 | | December 31, 2022 |
Assets | | | | |
Cash and cash equivalents | | $ | 138,906 | | | $ | 162,902 | |
Trade receivables, less allowance for credit loss of $6,901 and $6,769 | | 279,707 | | | 297,028 | |
Inventories (Note 4) | | 349,436 | | | 338,316 | |
Investments, short-term (Note 16) | | — | | | 9,905 | |
Prepaid income taxes | | 24,881 | | | 21,700 | |
Notes receivable, insurance companies (Note 17) | | — | | | 5,931 | |
Prepaid expenses and other current assets | | 38,367 | | | 44,344 | |
Total current assets | | 831,297 | | | 880,126 | |
| | | | |
Property, plant and equipment, net (Note 5) | | 207,115 | | | 207,552 | |
Operating lease right-of-use assets, net | | 43,541 | | | 44,142 | |
Prepaid pension cost (Note 14) | | 144,876 | | | 141,643 | |
Deferred tax assets (Note 10) | | 26,383 | | | 25,490 | |
Goodwill (Note 13) | | 623,443 | | | 620,622 | |
Intangible assets, net (Note 13) | | 278,359 | | | 281,853 | |
Notes receivable, insurance companies (Note 17) | | — | | | 38,695 | |
| | | | |
Insurance receivables (Note 17) and other noncurrent assets | | 24,656 | | | 136,853 | |
Total assets | | $ | 2,179,670 | | | $ | 2,376,976 | |
| | | | |
Liabilities | | | | |
Notes payable and current portion of long-term debt (Note 12) | | $ | 32,534 | | | $ | 7,387 | |
Accounts payable | | 106,225 | | | 112,532 | |
Employees’ compensation | | 33,104 | | | 45,077 | |
Insurance and product liability (Note 17) | | 9,911 | | | 73,898 | |
Income taxes payable (Note 10) | | 17,692 | | | 6,149 | |
Accrued restructuring (Note 3) and other current liabilities | | 93,065 | | | 100,822 | |
Total current liabilities | | 292,531 | | | 345,865 | |
| | | | |
Long-term debt, net (Note 12) | | 837,114 | | | 565,445 | |
Pensions and other employee benefits (Note 14) | | 139,065 | | | 137,810 | |
Noncurrent operating lease liabilities | | 34,583 | | | 35,345 | |
Deferred tax liabilities (Note 10) | | 102,532 | | | 31,881 | |
Product liability (Note 17) and other noncurrent liabilities | | 4,099 | | | 336,889 | |
Total liabilities | | $ | 1,409,924 | | | $ | 1,453,235 | |
| | | | |
Equity | | | | |
Preferred stock, 4.5% cumulative, $50 par value (Note 7) | | $ | 3,569 | | | $ | 3,569 | |
Common stock, no par value (Note 7) | | 287,009 | | | 281,980 | |
Treasury shares, at cost (Note 7) | | (363,879) | | | (361,438) | |
Accumulated other comprehensive loss (Note 6) | | (147,082) | | | (158,717) | |
Retained earnings | | 990,129 | | | 1,158,347 | |
| | | | |
| | | | |
Total shareholders’ equity | | 769,746 | | | 923,741 | |
Total liabilities and shareholders’ equity | | $ | 2,179,670 | | | $ | 2,376,976 | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Unaudited
| | | | | | | | | | | |
| Three Months Ended March 31, |
(In thousands) | 2023 | | 2022 |
Operating Activities | | | |
Net (loss) income | $ | (150,173) | | | $ | 35,542 | |
Depreciation and amortization | 14,572 | | | 14,165 | |
| | | |
Tax-effected loss on divestiture of MSA LLC (Note 17) | 199,578 | | | — | |
Stock-based compensation (Note 11) | 6,270 | | | 3,730 | |
Pension income (Note 14) | (2,020) | | | (2,652) | |
Deferred income tax benefit (Note 10) | (237) | | | (572) | |
Loss on asset dispositions, net | 739 | | | 4 | |
Pension contributions (Note 14) | (2,046) | | | (1,914) | |
Currency exchange losses, net | 4,175 | | | 3,271 | |
Product liability expense (Note 17) | 3 | | | 2,772 | |
Collections on insurance receivables and notes receivable, insurance companies (Note 17) | — | | | 3,865 | |
Product liability payments (Note 17) | (5,250) | | | (1,758) | |
Contribution on divestiture of MSA LLC (Note 17) | (341,186) | | | — | |
| | | |
Changes in: | | | |
Trade receivables | 21,662 | | | 13,365 | |
Inventories (Note 4) | (7,404) | | | (40,816) | |
Accounts payable | (7,320) | | | 1,408 | |
Other current assets and liabilities | (18,041) | | | (6,858) | |
Other noncurrent assets and liabilities | 769 | | | 971 | |
Cash Flow (Used in) From Operating Activities | (285,909) | | | 24,523 | |
Investing Activities | | | |
Capital expenditures | (8,402) | | | (7,976) | |
Proceeds from maturities of short-term investments (Note 16) | — | | | 29,000 | |
Purchase of short-term investments (Note 16) | — | | | (19,973) | |
Property disposals and other investing | 35 | | | — | |
| | | |
Cash Flow (Used in) From Investing Activities | (8,367) | | | 1,051 | |
Financing Activities | | | |
| | | |
Proceeds from long-term debt (Note 12) | 801,000 | | | 263,000 | |
Payments on long-term debt (Note 12) | (505,588) | | | (258,000) | |
Debt issuance costs | (913) | | | — | |
Cash dividends paid | (18,045) | | | (17,292) | |
Company stock purchases (Note 7) | (3,687) | | | (3,659) | |
Exercise of stock options (Note 7) | 4 | | | 51 | |
| | | |
| | | |
| | | |
| | | |
Cash Flow From (Used in) Financing Activities | 272,771 | | | (15,900) | |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (2,287) | | | (3,361) | |
(Decrease) increase in cash, cash equivalents and restricted cash | (23,792) | | | 6,313 | |
Beginning cash, cash equivalents and restricted cash | 164,428 | | | 141,438 | |
Ending cash, cash equivalents and restricted cash | $ | 140,636 | | | $ | 147,751 | |
| | | |
Supplemental cash flow information: | | | |
Cash and cash equivalents | $ | 138,906 | | | $ | 147,300 | |
Restricted cash included in prepaid expenses and other current assets | 1,730 | | | 451 | |
Total cash, cash equivalents and restricted cash | $ | 140,636 | | | $ | 147,751 | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN RETAINED EARNINGS
AND ACCUMULATED OTHER COMPREHENSIVE LOSS
Unaudited
| | | | | | | | | | | | | |
(In thousands, except per share values) | Retained Earnings | | Accumulated Other Comprehensive (Loss) | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Balances December 31, 2021 | $ | 1,050,214 | | | $ | (149,140) | | | |
Net income | 35,542 | | | — | | | |
Foreign currency translation adjustments | — | | | 5,892 | | | |
Pension and post-retirement plan adjustments, net of tax of $1,016 | — | | | 2,264 | | | |
Unrecognized net losses on available-for-sale securities (Note 16) | — | | | (9) | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Common dividends ($0.44 per share) | (17,282) | | | — | | | |
Preferred dividends ($0.5625 per share) | (10) | | | — | | | |
| | | | | |
Balances March 31, 2022 | $ | 1,068,464 | | | $ | (140,993) | | | |
| | | | | |
Balances December 31, 2022 | $ | 1,158,347 | | | $ | (158,717) | | | |
Net loss | (150,173) | | | — | | | |
Foreign currency translation adjustments | — | | | 11,194 | | | |
Pension and post-retirement plan adjustments, net of tax of $278 | — | | | 439 | | | |
Unrecognized net gains on available-for-sale securities (Note 16) | — | | | 2 | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Common dividends ($0.46 per share) | (18,035) | | | — | | | |
Preferred dividends ($0.5625 per share) | (10) | | | — | | | |
| | | | | |
Balances March 31, 2023 | $ | 990,129 | | | $ | (147,082) | | | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MSA SAFETY INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
Note 1—Basis of Presentation
The condensed consolidated financial statements of MSA Safety Incorporated and its subsidiaries ("MSA" or "the Company") are unaudited. These unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, considered necessary by management to fairly state the Company's results. Intercompany accounts and transactions have been eliminated. The results reported in these unaudited condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the entire year. The December 31, 2022, Balance Sheet data was derived from the audited Consolidated Balance Sheet, but does not include all disclosures required by accounting principles generally accepted in the United States of America ("U.S. GAAP"). This Form 10-Q report should be read in conjunction with MSA's Form 10-K for the year ended December 31, 2022, which includes all disclosures required by U.S. GAAP.
Note 2—Cash and Cash Equivalents
Several of the Company's subsidiaries participate in a notional cash pooling arrangement to manage global liquidity requirements. As part of a master netting arrangement, the participants combine their cash balances in pooling accounts at the same financial institution with the ability to offset bank overdrafts of one participant against positive cash account balances held by another participant. Under the terms of the master netting arrangement, the financial institution has the right, ability and intent to offset a positive balance in one account against an overdrawn amount in another account. Amounts in each of the accounts are unencumbered and unrestricted with respect to use. As such, the net cash balance related to this pooling arrangement is included in Cash and cash equivalents in the unaudited Condensed Consolidated Balance Sheets.
The Company's net cash pool position consisted of the following:
| | | | | | | | |
(In thousands) | | March 31, 2023 |
Gross cash pool position | | $ | 71,897 | |
Less: cash pool borrowings | | (68,198) | |
Net cash pool position | | $ | 3,699 | |
Note 3—Restructuring Charges
During the three months ended March 31, 2023, we recorded restructuring charges of $1.7 million. Americas segment restructuring charges of $1.4 million during the three months ended March 31, 2023, were related to manufacturing footprint optimization activities. Corporate segment restructuring charges of $0.6 million during the three months ended March 31, 2023 were primarily related to various optimization activities.
During the three months ended March 31, 2022, we recorded restructuring charges of $2.2 million. International segment restructuring charges of $2.0 million during the three months ended March 31, 2022, were primarily related to the expansion of our European Shared Service Center in Warsaw, Poland. Americas segment restructuring charges of $0.4 million during the three months ended March 31, 2022, were primarily related to programs to adjust our operations in response to current business conditions.
Restructuring reserves are included in Accrued restructuring and other current liabilities in the accompanying unaudited Condensed Consolidated Balance Sheets. Activity and reserve balances for restructuring by segment were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
(In millions) | Americas | | International | | Corporate | | Total |
Reserve balances at December 31, 2021 | $ | 3.3 | | | $ | 17.4 | | | $ | 0.3 | | | $ | 21.0 | |
Restructuring charges | 2.3 | | | 5.1 | | | 0.6 | | | 8.0 | |
Currency translation | 0.1 | | | (1.3) | | | — | | | (1.2) | |
Cash payments / utilization | (4.0) | | | (8.4) | | | (0.4) | | | (12.8) | |
Reserve balances at December 31, 2022 | $ | 1.7 | | | $ | 12.8 | | | $ | 0.5 | | | $ | 15.0 | |
Restructuring charges (adjustments) | 1.4 | | | (0.3) | | | 0.6 | | | 1.7 | |
Currency translation | — | | | 0.2 | | | — | | | 0.2 | |
Cash payments | (2.0) | | | (2.7) | | | (0.7) | | | (5.4) | |
Reserve balances at March 31, 2023 | $ | 1.1 | | | $ | 10.0 | | | $ | 0.4 | | | $ | 11.5 | |
Note 4—Inventories
The following table sets forth the components of inventory:
| | | | | | | | | | | | | | |
(In thousands) | | March 31, 2023 | | December 31, 2022 |
Finished products | | $ | 97,360 | | | $ | 97,142 | |
Work in process | | 22,141 | | | 16,360 | |
Raw materials and supplies | | 229,935 | | | 224,814 | |
Total inventories | | $ | 349,436 | | | $ | 338,316 | |
Note 5—Property, Plant and Equipment
The following table sets forth the components of property, plant and equipment, net:
| | | | | | | | | | | |
(In thousands) | March 31, 2023 | | December 31, 2022 |
Land | $ | 4,932 | | | $ | 4,884 | |
| | | |
Buildings | 140,155 | | | 138,618 | |
Machinery and equipment | 475,707 | | | 466,394 | |
Construction in progress | 21,107 | | | 22,097 | |
Total | 641,901 | | | 631,993 | |
Less: accumulated depreciation | (434,786) | | | (424,441) | |
Property, plant and equipment, net | $ | 207,115 | | | $ | 207,552 | |
Note 6—Reclassifications Out of Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive loss were as follows:
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
(In thousands) | 2023 | | 2022 | | | | |
Pension and other post-retirement benefits (a) | | | | | | | |
Balance at beginning of period | $ | (50,335) | | | $ | (57,296) | | | | | |
Amounts reclassified from accumulated other comprehensive loss into net (loss) income: | | | | | | | |
Amortization of prior service credit (Note 14) | (24) | | | (48) | | | | | |
Recognized net actuarial losses (Note 14) | 185 | | | 3,328 | | | | | |
Tax expense (benefit) | 278 | | | (1,016) | | | | | |
Total amount reclassified from accumulated other comprehensive loss, net of tax, into net (loss) income | 439 | | | 2,264 | | | | | |
| | | | | | | |
Balance at end of period | $ | (49,896) | | | $ | (55,032) | | | | | |
Available-for-sale securities | | | | | | | |
Balance at beginning of period | $ | (2) | | | $ | (5) | | | | | |
Unrealized net gains (losses) on available-for-sale securities (Note 16) | 2 | | | (9) | | | | | |
Balance at end of period | $ | — | | | $ | (14) | | | | | |
Foreign currency translation | | | | | | | |
Balance at beginning of period | $ | (108,380) | | | $ | (91,839) | | | | | |
| | | | | | | |
| | | | | | | |
Foreign currency translation adjustments | 11,194 | | | 5,892 | | | | | |
Balance at end of period | $ | (97,186) | | | $ | (85,947) | | | | | |
(a) Reclassifications out of accumulated other comprehensive loss and into net (loss) income are included in the computation of net periodic pension and other post-retirement benefit costs (refer to Note 14—Pensions and Other Post-retirement Benefits). | | | | |
Note 7—Capital Stock
Preferred Stock - The Company has authorized 100,000 shares of $50 par value 4.5% cumulative preferred nonvoting stock which is callable at $52.50. There are 71,340 shares issued and 52,998 shares held in treasury at both March 31, 2023 and December 31, 2022. The Treasury shares at cost line in the unaudited Condensed Consolidated Balance Sheets includes $1.8 million related to preferred stock. There were no shares of preferred stock purchased and subsequently held in treasury during the three months ended March 31, 2023, or 2022. The Company has also authorized 1,000,000 shares of $10 par value second cumulative preferred voting stock. No shares have been issued as of March 31, 2023, or December 31, 2022.
Common Stock - The Company has authorized 180,000,000 shares of no par value common stock. There were 62,081,391 shares issued as of March 31, 2023, and December 31, 2022. No new shares were issued during the three months ended March 31, 2023, or 2022. There were 39,264,779 and 39,213,064 shares outstanding at March 31, 2023, and December 31, 2022, respectively.
Treasury Shares - The Company's stock repurchase program authorizes up to $100.0 million to repurchase MSA common stock in the open market and in private transactions. The stock repurchase program has no expiration date. The maximum number of shares that may be repurchased is calculated based on the dollars remaining under the program and the respective month-end closing share price. During the three months ended March 31, 2023, and 2022, no shares were repurchased under this program. There were 22,816,612 and 22,868,327 Treasury shares at March 31, 2023, and December 31, 2022, respectively.
The Company issues Treasury shares for all stock-based benefit plans. Shares are issued from Treasury at the average Treasury share cost on the date of the transaction. There were 26,774 and 28,366 Treasury shares issued for these purposes during the three months ended March 31, 2023, and 2022, respectively.
Common stock activity is summarized as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2023 | | Three Months Ended March 31, 2022 |
(In thousands) | Common Stock | | Treasury Cost | | Common Stock | | Treasury Cost |
Balance at beginning of period | $ | 281,980 | | | $ | (359,838) | | | $ | 260,121 | | | $ | (328,776) | |
Stock compensation expense | 6,270 | | | — | | | 3,730 | | | — | |
Restricted and performance stock awards | (1,244) | | | 1,244 | | | (1,260) | | | 1,260 | |
Stock options exercised | 3 | | | 1 | | | 36 | | | 15 | |
Treasury shares purchased for stock compensation programs | — | | | (3,687) | | | — | | | (3,659) | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Balance at end of period | $ | 287,009 | | | $ | (362,280) | | | $ | 262,627 | | | $ | (331,160) | |
Note 8—Segment Information
We are organized into four geographical operating segments that are based on management responsibilities: Northern North America, Latin America, Europe, Middle East & Africa, and Asia Pacific. The operating segments have been aggregated (based on economic similarities, the nature of their products, end-user markets and methods of distribution) into three reportable segments: Americas, International, and Corporate.
The Americas segment is comprised of our operations in Northern North American and Latin American geographies. The International segment is comprised of our operations in all geographies outside of the Americas. Certain global expenses are allocated to each segment in a manner consistent with where the benefits from the expenses are derived.
The Company's sales are allocated to each segment based primarily on the country destination of the end-customer.
Adjusted operating income (loss), adjusted operating margin, adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA margin are the measures used by the chief operating decision maker to evaluate segment performance and allocate resources. Adjusted operating income (loss) is defined as operating income (loss) excluding restructuring charges, currency exchange (gains) losses, product liability expense, loss on divestiture of MSA LLC, transaction costs and acquisition-related amortization. Adjusted operating margin is defined as adjusted operating income (loss) divided by segment net sales to external customers. Adjusted EBITDA is defined as adjusted operating income (loss) plus depreciation and amortization. Adjusted EBITDA margin is defined as adjusted EBITDA divided by segment net sales to external customers.
The accounting principles applied at the operating segment level in determining operating income (loss) are generally the same as those applied at the unaudited condensed consolidated financial statement level. Sales and transfers between operating segments are accounted for at market-based transaction prices and are eliminated in consolidation.
Reportable segment information is presented in the following table: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(In thousands, except percentages) | | Americas | | International | | Corporate | | | | Consolidated Totals |
Three Months Ended March 31, 2023 | | | | | | | | | | |
Net sales to external customers | | $ | 280,267 | | | $ | 117,995 | | | $ | — | | | | | $ | 398,262 | |
| | | | | | | | | | |
Operating loss | | | | | | | | | | (60,061) | |
Restructuring charges (Note 3) | | | | | | | | | | 1,747 | |
Currency exchange losses, net | | | | | | | | | | 4,175 | |
Loss on divestiture of MSA LLC (Note 17) | | | | | | | | | | 129,211 | |
Product liability expense (Note 17) | | | | | | | | | | 3 | |
Amortization of acquisition-related intangible assets | | | | | | | | | | 2,305 | |
| | | | | | | | | | |
| | | | | | | | | | |
Adjusted operating income (loss) | | 71,694 | | | 15,779 | | | (10,093) | | | | | 77,380 | |
Adjusted operating margin % | | 25.6 | % | | 13.4 | % | | | | | | |
Depreciation and amortization | | | | | | | | | | 12,267 | |
Adjusted EBITDA | | 80,494 | | | 19,058 | | | (9,905) | | | | | 89,647 | |
Adjusted EBITDA margin % | | 28.7 | % | | 16.2 | % | | | | | | |
| | | | | | | | | | |
Three Months Ended March 31, 2022 | | | | | | | | | | |
Net sales to external customers | | $ | 225,648 | | | $ | 105,044 | | | $ | — | | | | | $ | 330,692 | |
| | | | | | | | | | |
Operating income | | | | | | | | | | 42,668 | |
Restructuring charges (Note 3) | | | | | | | | | | 2,189 | |
Currency exchange losses, net | | | | | | | | | | 3,271 | |
Product liability expense (Note 17) | | | | | | | | | | 2,772 | |
Amortization of acquisition-related intangible assets | | | | | | | | | | 2,336 | |
Transaction costs(a) | | | | | | | | | | 607 | |
| | | | | | | | | | |
Adjusted operating income (loss) | | 52,435 | | | 9,024 | | | (7,616) | | | | | 53,843 | |
Adjusted operating margin % | | 23.2 | % | | 8.6 | % | | | | | | |
Depreciation and amortization | | | | | | | | | | 11,829 | |
Adjusted EBITDA | | 60,796 | | | 12,362 | | | (7,486) | | | | | 65,672 | |
Adjusted EBITDA margin % | | 26.9 | % | | 11.8 | % | | | | | | |
(a) Transaction costs include advisory, legal, accounting, valuation, and other professional or consulting fees incurred during acquisitions and divestitures. These costs are included in Selling, general and administrative expense in the unaudited Condensed Consolidated Statements of Operations. |
| | | | | | | | | | |
Total sales by product group was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Three Months Ended March 31, 2023 | Consolidated | | Americas | | International |
(In thousands, except percentages) | Dollars | Percent | | Dollars | Percent | | Dollars | Percent |
Fixed Gas & Flame Detection | $ | 93,635 | | 24% | | $ | 61,143 | | 22% | | $ | 32,492 | | 28% |
Breathing Apparatus | 76,721 | | 19% | | 52,769 | | 19% | | 23,952 | | 20% |
Firefighter Helmets & Protective Apparel | 62,667 | | 16% | | 49,287 | | 18% | | 13,380 | | 11% |
Portable Gas Detection | 52,966 | | 13% | | 38,168 | | 14% | | 14,798 | | 13% |
Industrial Head Protection | 42,907 | | 11% | | 33,625 | | 12% | | 9,282 | | 8% |
Fall Protection | 31,157 | | 8% | | 20,458 | | 7% | | 10,699 | | 9% |
Other | 38,209 | | 9% | | 24,817 | | 8% | | 13,392 | | 11% |
Total | $ | 398,262 | | 100% | | $ | 280,267 | | 100% | | $ | 117,995 | | 100% |
| | | | | | | | |
Three Months Ended March 31, 2022 | Consolidated | | Americas | | International |
(In thousands, except percentages) | Dollars | Percent | | Dollars | Percent | | Dollars | Percent |
Fixed Gas & Flame Detection | $ | 83,077 | | 25% | | $ | 54,621 | | 24% | | $ | 28,456 | | 27% |
Breathing Apparatus | 70,951 | | 22% | | 50,398 | | 22% | | 20,553 | | 20% |
Firefighter Helmets & Protective Apparel | 48,461 | | 15% | | 33,476 | | 15% | | 14,985 | | 14% |
Portable Gas Detection | 36,744 | | 11% | | 25,791 | | 11% | | 10,953 | | 10% |
Industrial Head Protection | 36,157 | | 11% | | 28,165 | | 13% | | 7,992 | | 8% |
Fall Protection | 24,662 | | 7% | | 16,277 | | 7% | | 8,385 | | 8% |
Other | 30,640 | | 9% | | 16,920 | | 8% | | 13,720 | | 13% |
Total | $ | 330,692 | | 100% | | $ | 225,648 | | 100% | | $ | 105,044 | | 100% |
Note 9—(Loss) Earnings per Share
Basic (loss) earnings per share is computed by dividing net income, after the deduction of preferred stock dividends and undistributed earnings allocated to participating securities, by the weighted average number of common shares outstanding during the period. Diluted (loss) earnings per share assumes the issuance of common stock for all potentially dilutive share equivalents outstanding not classified as participating securities. Participating securities are defined as unvested stock-based compensation awards that contain nonforfeitable rights to dividends.
| | | | | | | | | | | | | | | | | | | | |
| | | | Three Months Ended March 31, |
(In thousands, except per share values) | | | | | | 2023 | | 2022 |
Net (loss) income | | | | | | $ | (150,173) | | | $ | 35,542 | |
Preferred stock dividends | | | | | | (10) | | | (10) | |
Net (loss) income available to common equity | | | | | | (150,183) | | | 35,532 | |
Dividends and undistributed earnings allocated to participating securities | | | | | | — | | | (4) | |
Net (loss) income available to common shareholders | | | | | | (150,183) | | | 35,528 | |
| | | | | | | | |
Basic weighted-average shares outstanding | | | | | | 39,224 | | | 39,291 | |
Stock-based compensation awards (a) | | | | | | — | | | 232 | |
Diluted weighted-average shares outstanding | | | | | | 39,224 | | | 39,523 | |
Antidilutive shares | | | | | | 180 | | | — | |
| | | | | | | | |
(Loss) earnings per share: | | | | | | | | |
Basic | | | | | | $ | (3.83) | | | $ | 0.90 | |
Diluted | | | | | | $ | (3.83) | | | $ | 0.90 | |
(a) During periods in which the Company incurs a net loss, stock-based compensation awards are excluded from the computation of diluted earnings per share because their effect would be anti-dilutive. As such, during periods in which the Company incurs a net loss, diluted weighted average shares outstanding are equivalent to basic weighted average shares outstanding. |
Note 10—Income Taxes
The Company's effective tax rate for the three months ended March 31, 2023, was (121.7)%, which differs from the United States of America ("U.S.") federal statutory rate of 21% primarily due to the divestiture of MSA LLC and the non-deductible loss recorded on the derecognition of the product liability reserves and related assets. Refer to Note 17—Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further information on this transaction. The Company's effective tax rate for the three months ended March 31, 2022, was 21.7%, which differs from the U.S. federal statutory rate of 21% primarily due to state income taxes partially offset by tax benefits on certain share-based payments.
At March 31, 2023, the Company had a gross liability for unrecognized tax benefits of $3.4 million. The Company has recognized tax benefits associated with these liabilities of $1.8 million at March 31, 2023. The gross liability includes amounts associated with foreign tax exposure in prior periods.
The Company recognizes interest and penalties related to unrecognized tax benefits in interest expense and operating expenses, respectively. The Company's liability for accrued interest related to uncertain tax positions was $0.3 million at March 31, 2023.
We are subject to regular review and audit by both foreign and domestic tax authorities. While we believe our tax positions will be sustained, the final outcome of tax audits and related litigation may differ materially from the tax amounts recorded in our unaudited condensed consolidated financial statements.
Note 11—Stock Plans
The 2016 Management Equity Incentive Plan provides for various forms of stock-based compensation for eligible employees through May 2026 including stock options, restricted stock awards, restricted stock units and performance stock units. The 2017 Non-Employee Directors’ Equity Incentive Plan provides for grants of stock options and restricted stock to non-employee directors through May 2027.
Stock compensation expense, included in Selling, general and administrative expense in the unaudited Condensed Consolidated Statements of Operations, is as follows:
| | | | | | | | | | | | | | | | | | | | |
| | | | Three Months Ended March 31, |
(In thousands) | | | | | | 2023 | | 2022 |
Stock compensation expense | | | | | | $ | 6,270 | | | $ | 3,730 | |
Income tax benefit | | | | | | 1,536 | | | 914 | |
Stock compensation expense, net of tax | | | | | | $ | 4,734 | | | $ | 2,816 | |
We have not capitalized any stock-based compensation expense.
A summary of stock option activity for the three months ended March 31, 2023, is as follows:
| | | | | | | | | | | | | | |
| | Shares | | Weighted Average Exercise Price |
Outstanding at January 1, 2023 | | 58,156 | | | $ | 46.48 | |
| | | | |
Exercised | | (76) | | | 48.41 | |
| | | | |
| | | | |
Outstanding and exercisable at March 31, 2023 | | 58,080 | | | $ | 46.47 | |
| | | | |
Restricted stock awards and restricted stock units are valued at the market value of the stock on the grant date. A summary of restricted stock activity for the three months ended March 31, 2023, is as follows:
| | | | | | | | | | | | | | |
| | Shares | | Weighted Average Grant Date Fair Value |
Unvested at January 1, 2023 | | 145,886 | | | $ | 137.36 | |
Granted | | 52,883 | | | 133.72 | |
Vested | | (26,763) | | | 126.16 | |
Forfeited | | (1,744) | | | 136.41 | |
Unvested at March 31, 2023 | | 170,262 | | | $ | 138.20 | |
Performance stock units that have a market condition modifier are valued at an estimated fair value using a Monte Carlo model. The final number of shares to be issued for performance stock units granted in the first quarter of 2023 may range from 0% to 200% of the target award based on achieving the specified performance targets over the performance period plus an additional modifier based on total shareholder return ("TSR") over the performance period. The following weighted average assumptions were used in estimating the fair value of the performance stock units granted for the three months ended March 31, 2023.
| | | | | | | | |
Fair value per unit | $131.46 | | | |
Risk-free interest rate | 4.4% | | | |
Expected dividend yield | 1.43% | | | |
Expected volatility | 36.7% | | | |
MSA stock beta | 0.739 | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
The risk-free interest rate is based on the U.S. Treasury Constant Maturity rates as of the grant date converted into an implied spot rate yield curve. Expected dividend yield is based on the most recent annualized dividend divided by the one year average closing share price. Expected volatility is based on the three year historical volatility preceding the grant date using daily stock prices. Expected life is based on historical stock option exercise data.
A summary of performance stock unit activity for the three months ended March 31, 2023, is as follows:
| | | | | | | | | | | | | | |
| | Shares | | Weighted Average Grant Date Fair Value |
Unvested at January 1, 2023 | | 178,760 | | | $ | 146.28 | |
Granted | | 75,425 | | | 131.46 | |
Performance adjustments(a) | | (3,009) | | | 127.40 | |
Vested | | (53,407) | | | 127.36 | |
Forfeited | | (796) | | | 139.27 | |
Unvested at March 31, 2023 | | 196,973 | | | $ | 146.05 | |
(a)Performance adjustments relate primarily to the final number of shares issued for the 2020 performance unit awards which vested in the first quarter of 2023 at 94.9% of the target award based on both cumulative performance against EBITDA margin and revenue growth targets and MSA's TSR during the three-year performance period. |
Note 12—Long-Term Debt
| | | | | | | | | | | |
(In thousands) | March 31, 2023 | | December 31, 2022 |
2016 Senior Notes payable through 2031, 3.40%, net of debt issuance costs | $ | 60,167 | | | $ | 66,379 | |
2021 Senior Notes payable through 2036, 2.69%, net of debt issuance costs | 99,717 | | | 99,711 | |
2021 Senior Notes payable through 2036, 2.69%, net of debt issuance costs | 99,717 | | | 99,711 | |
2023 Term Loan credit agreement maturing in 2026, net of debt issuance costs | 249,145 | | | — | |
Senior revolving credit facility maturing in 2026, net of debt issuance costs | 360,902 | | | 307,031 | |
Total | 869,648 | | | 572,832 | |
Amounts due within one year | 32,534 | | | 7,387 | |
Long-term debt, net of debt issuance costs | $ | 837,114 | | | $ | 565,445 | |
On May 24, 2021, the Company entered into a Fourth Amended and Restated Credit Agreement (the “Revolving Credit Facility" or "Facility”) that extended its term through May 24, 2026 and increased the capacity to $900.0 million. Under the amended agreement, the Company may elect either a Base rate of interest (“BASE”) or an interest rate based on the London Interbank Offered Rate (“LIBOR”). The BASE is a daily fluctuating per annum rate equal to the highest of (i) 0.00%, (ii) the Prime Rate, (iii) the Federal Funds Open Rate plus one half of one percent (0.5%), (iv) the Overnight Bank Funding Rate, plus one half of one percent (0.5%), or (v) the Daily LIBOR Rate plus one percent (1.00%). The Company pays a credit spread of 0 to 175 basis points based on the Company’s net EBITDA leverage ratio and elected rate (BASE or LIBOR). The Company has a weighted average revolver interest rate of 5.74% as of March 31, 2023. At March 31, 2023, $536.1 million of the existing $900.0 million Revolving Credit Facility was unused, including letters of credit issued under the Facility. The Facility also provides an accordion feature that allows the Company to access an additional $400.0 million of capacity pending approval by MSA’s board of directors and from the bank group.
On July 1, 2021, the Company entered into a Third Amended and Restated Multi-Currency Note Purchase and Private Shelf Agreement (the “Prudential Note Agreement”) with PGIM, Inc. (“Prudential”). The Prudential Note Agreement provided for (i) the issuance of $100.0 million of 2.69% Series C Senior Notes due July 1, 2036 and (ii) the establishment of an uncommitted note issuance facility whereby the Company may request, subject to Prudential’s acceptance in its sole discretion, the issuance of up to $335.0 million aggregate principal amount of senior unsecured notes. As of March 31, 2023, the Company has outstanding £48.8 million (approximately $60.3 million at March 31, 2023) of 3.4% Series B Senior Notes due January 22, 2031. Remaining maturities of this note are £6.1 million (approximately $7.5 million at March 31, 2023) due January 22, 2024, with annual maturities of £6.1 million through January 2031.
On July 1, 2021, the Company entered into a Second Amended and Restated Master Note Facility (the “NYL Note Facility”) with NYL Investors. The NYL Note Facility provided for (i) the issuance of $100.0 million of 2.69% Series A Senior Notes due July 1, 2036, and (ii) the establishment of an uncommitted note issuance facility whereby the Company may request, subject to NYL Investors’ acceptance in its sole discretion, the issuance of up to $200.0 million aggregate principal amount of senior unsecured notes.
The Revolving Credit Facility, Prudential Note Agreement and NYL Note Facility require the Company to comply with specified financial covenants, including a requirement to maintain a minimum fixed charges coverage ratio of not less than 1.50 to 1.00 and a consolidated leverage ratio not to exceed 3.50 to 1.00; except during an acquisition period, defined as four consecutive fiscal quarters beginning with the quarter of acquisition, in which case the consolidated net leverage ratio shall not exceed 4.00 to 1.00; in each case calculated on the basis of the trailing four fiscal quarters. In addition, the agreements contain negative covenants limiting the ability of the Company and its subsidiaries to incur additional indebtedness or issue guarantees, create or incur liens, make loans and investments, make acquisitions, transfer or sell assets, enter into transactions with affiliated parties, make changes in its organizational documents that are materially adverse to lenders or modify the nature of the Company's or its subsidiaries' business. All credit facilities exclude Mine Safety Appliances Company, LLC prior to the divestiture of this subsidiary on January 5, 2023, as discussed further in Note 17.
During August 2021, the Company amended its Revolving Credit Facility to transition from Sterling LIBOR reference rates to Sterling Overnight Interbank Average Rate ("SONIA") reference rates. The Company will apply the optional expedients in ASC 848, Reference Rate Reform, to this modification and potential future modifications driven by reference rate reform, accounting for the modifications as a continuation of the existing contracts. Therefore, these modifications will not require remeasurement at the modification date or a reassessment of previous accounting determinations. As such, the Company does not anticipate the change in reference rates will have an impact on the Company’s unaudited condensed consolidated financial statements. Management continues to evaluate the Company’s other outstanding U.S. LIBOR based contracts to determine whether reference rate modifications are necessary.
On January 5, 2023, the Company entered into a new $250 million term loan facility to fund the divestiture of MSA LLC, a wholly owned subsidiary. Under the agreement, the Company may elect either BASE or an interest rate based on the Secured Overnight Financing Rate. The Company pays a credit spread of 0 to 200 basis points based on the Company's net EBITDA leverage ratio and elected rate. The Company had a Term Loan interest rate of 6.22% as of March 31, 2023.
As of March 31, 2023, the Company was in full compliance with the restrictive covenants under its various credit agreements.
The Company had outstanding bank guarantees and standby letters of credit with banks as of March 31, 2023, totaling $9.7 million, of which $